Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 24Gastrointestinal 5Thoracic 4Genitourinary 3Gynecologic 2Dermatologic 2Breast 2Other neoplasm 1Lymphoid 1

Conditions

Precancerous Conditions 2Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Papillomavirus Infections 1Pancreatic Cyst 1Head and Neck Neoplasms 1Gastric Adenocarcinoma 1Clinical Stage IVB Gastric Cancer AJCC v8 1

Interventions

Radiotherapy, Intensity-Modulated 2Cisplatin 2Cetuximab 2vandetanib 1Video-Assisted Surgery 1Photochemotherapy 1Paclitaxel 1Immunohistochemistry 1Gene Expression Profiling 1Dihematoporphyrin Ether 1Comparative Genomic Hybridization 1Biopsy 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Albumin-Bound Paclitaxel × Other neoplasm × Clear all
NCT01084083 2023-06-28

Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer

Eastern Cooperative Oncology Group

Phase 2 Completed
90 enrolled 7 charts
Head & NeckOther neoplasm

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Precancerous Conditions, Tongue Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡